MedTrace Logo

Delirium in Covid-19: Germany-wide Covid-19 Intensive Register

NCT04775017 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2398

Last updated 2024-10-29

No results posted yet for this study

Summary

The global pandemic caused by the SARS-CoV-2 virus is confronting the German health system with a novel pathogen. This means that a timely evaluation of all available results is required. In the field of intensive care in particular, there are significant gaps in knowledge, particularly with regard to delirium. In this respect, this study also serves directly to investigate the pathways of delirium outcome in COVID-19 patients.

Conditions

  • Intensive Care Unit Delirium
  • Covid19
  • Post Intensive Care Unit Syndrome

Sponsors & Collaborators

  • Charite University, Berlin, Germany

    lead OTHER

Principal Investigators

  • Claudia Spies, MD, Prof. · Charité - Universitäsmedizin Berlin

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-01
Primary Completion
2022-02-21
Completion
2022-08-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04775017 on ClinicalTrials.gov